Friday July 31, 2009
Start: 00:00
Start: 07/31/2009 - 00:00
End: 08/04/2009 - 18:00
At the 13th World Conference on Lung Cancer, our objectives are to:
- Share and discuss recent advances in prevention, imaging, early detection and treatment of lung cancer
- Review advances in the molecular biology and pharmacogenomics of lung cancer and how they apply to personalizing medicine
- Discuss tobacco control methods being utilized throughout the world
- Evaluate results from recent clinical trials related to lung cancer and mesothelioma
- Review palliative care options for patients with lung cancer
- Support the career development of fellows and junior faculty with an interest in lung cancer
Notes taken from IASLC website
Speakers include: Professor John K Field, Director of The Roy Castle Lung Cancer Research Programme and Dr Jesme Fox, Medical & Policy Director of The Roy Castle Lung Cancer Foundation
Saturday August 1, 2009
(all day)
Start: 07/31/2009 - 00:00
End: 08/04/2009 - 18:00
At the 13th World Conference on Lung Cancer, our objectives are to:
- Share and discuss recent advances in prevention, imaging, early detection and treatment of lung cancer
- Review advances in the molecular biology and pharmacogenomics of lung cancer and how they apply to personalizing medicine
- Discuss tobacco control methods being utilized throughout the world
- Evaluate results from recent clinical trials related to lung cancer and mesothelioma
- Review palliative care options for patients with lung cancer
- Support the career development of fellows and junior faculty with an interest in lung cancer
Notes taken from IASLC website
Speakers include: Professor John K Field, Director of The Roy Castle Lung Cancer Research Programme and Dr Jesme Fox, Medical & Policy Director of The Roy Castle Lung Cancer Foundation
Sunday August 2, 2009
(all day)
Start: 07/31/2009 - 00:00
End: 08/04/2009 - 18:00
At the 13th World Conference on Lung Cancer, our objectives are to:
- Share and discuss recent advances in prevention, imaging, early detection and treatment of lung cancer
- Review advances in the molecular biology and pharmacogenomics of lung cancer and how they apply to personalizing medicine
- Discuss tobacco control methods being utilized throughout the world
- Evaluate results from recent clinical trials related to lung cancer and mesothelioma
- Review palliative care options for patients with lung cancer
- Support the career development of fellows and junior faculty with an interest in lung cancer
Notes taken from IASLC website
Speakers include: Professor John K Field, Director of The Roy Castle Lung Cancer Research Programme and Dr Jesme Fox, Medical & Policy Director of The Roy Castle Lung Cancer Foundation
